Paul DiSilvestro

Paul DiSilvestro

UNVERIFIED PROFILE

Are you Paul DiSilvestro?   Register this Author

Register author
Paul DiSilvestro

Paul DiSilvestro

Publications by authors named "Paul DiSilvestro"

Are you Paul DiSilvestro?   Register this Author

65Publications

1548Reads

32Profile Views

Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?

Gynecol Oncol 2019 07 13;154(1):150-155. Epub 2019 Apr 13.

Center for Biomarkers and Emerging Technologies, Women and Infants Hospital/Brown University, RI 02905, USA; Department of Pathology, Women and Infants Hospital/Brown University, RI 02905, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258193050
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2019.04.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666425PMC
July 2019

Shaping the standard of care in ovarian cancer management: A review of Gynecologic Oncology Group (GOG)/NRG oncology clinical trials of the past twenty years.

Gynecol Oncol 2019 06 22;153(3):479-486. Epub 2019 Mar 22.

Women and Infants Hospital, Alpert School of Medicine at Brown University, 101 Dudley Street, Providence, RI 02905, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.02.020DOI Listing
June 2019

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.

N Engl J Med 2019 06;380(24):2317-2326

From Northwestern University (D. Matei) and Loyola University (W.S.) - both in Chicago; NRG Oncology Statistical and Data Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY (V.F., H.Q.H.); University of Kentucky, Lexington (M.E.R.); Washington University School of Medicine, Siteman Cancer Center, St. Louis (D. Mutch, M.A.P.); Women and Infants Hospital in Rhode Island-The Warren Alpert Medical School of Brown University, Providence (M.M.S., P.A.D.); Stephenson Cancer Center Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City (K.M.M.); Asan Medical Center, University of Ulsan, Songpa-gu, Seoul, South Korea (Y.M.K.); Ohio State University, Columbus (D.M.O.); Women's Cancer Center of Nevada, Las Vegas (N.M.S.); University of California Irvine Medical Center, Irvine (K.S.T.); Lewis Cancer and Research Pavilion at St. Joseph's-Candler, Savannah, GA (W.E.R.); Case Western Reserve University Hospital, Cleveland (J.N.); Dana-Farber Cancer Institute, Boston (U.A.M.); and the University of Texas Southwestern Medical Center, Dallas (D.S.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1813181DOI Listing
June 2019

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Lancet Oncol 2019 May 1;20(5):636-648. Epub 2019 Apr 1.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St Joseph's Hospital, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30029-4DOI Listing
May 2019

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes.

Oncotarget 2019 May 21;10(36):3315-3327. Epub 2019 May 21.

Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534361PMC
May 2019

Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins.

Oncotarget 2019 Apr 26;10(31):2959-2972. Epub 2019 Apr 26.

Division of Gynecologic Oncology, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508204PMC
April 2019

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

N Engl J Med 2018 12 21;379(26):2495-2505. Epub 2018 Oct 21.

From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan-Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica, Rome (G.S.) - both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (A. Oaknin), and M.D. Anderson Cancer Centre Madrid, Madrid (A.G.-M.) - both in Spain; University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia (M.F.); St. Petersburg City Oncology Dispensary, St. Petersburg, Russia (A. Lisyanskaya); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Paris (A.F., A. Leary), Institut Bergonié, Comprehensive Cancer Center, Bordeaux (A.F.), and Gustave-Roussy Cancer Campus, Villejuif (A. Leary) - all in France; the Netherlands Cancer Institute, Amsterdam (G.S.S.); Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (C.G.), the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London (S.B.), and AstraZeneca, Cambridge (R.B.) - all in the United Kingdom; Princess Margaret Cancer Centre, Toronto (A. Oza); Memorial Sloan Kettering Cancer Center, New York (C.A.); Froedtert and the Medical College of Wisconsin, Milwaukee (W.B.); Women and Infants Hospital, Providence, RI (C.M., P.D.); Dana-Farber Cancer Institute, Boston (J.L.); and AstraZeneca, Gaithersburg, MD (E.S.L.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1810858
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1810858DOI Listing
December 2018

While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularity.

Am J Obstet Gynecol 2018 10 29;219(4):381.e1-381.e10. Epub 2018 Jul 29.

Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Providence, RI; Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Providence, RI; Warren Alpert Medical School of Brown University, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2018.07.024DOI Listing
October 2018

Maintenance treatment of recurrent ovarian cancer: Is it ready for prime time?

Cancer Treat Rev 2018 Sep 5;69:53-65. Epub 2018 Jun 5.

Gynecology Oncology, Duke Cancer Institute, Durham, NC, United States; The Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Durham, NC, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183009
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.06.001DOI Listing
September 2018

Anal and Cervical High-Risk Human Papillomavirus Genotyping in Women With and Without Genital Neoplasia.

J Low Genit Tract Dis 2018 Apr;22(2):115-119

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LGT.0000000000000368DOI Listing
April 2018

Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer Regulation of the Extracelluar Matrix.

Front Oncol 2017 22;7:332. Epub 2018 Jan 22.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Program in Women's Oncology, Women and Infants Hospital, Providence, RI, United States.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fonc.2017.003
Publisher Site
http://dx.doi.org/10.3389/fonc.2017.00332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786890PMC
January 2018

Management of Low-Grade Cervical Müllerian Adenosarcoma in a 14-Year-Old Girl.

J Pediatr Adolesc Gynecol 2017 Dec 1;30(6):652-654. Epub 2017 Jun 1.

Department of Gynecologic Oncology, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpag.2017.05.010DOI Listing
December 2017

Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.

Radiology 2017 05 3;283(2):450-459. Epub 2017 Jan 3.

From the Department of Medical Imaging, NCSB 1C569 Toronto General Hospital, University of Toronto, University Health Network, 585 University Ave, Toronto, ON, Canada M5G 2N2 (M.A.); Center for Statistical Sciences, Brown University, Providence, RI (F.D., H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (F.D.); Department of Radiology, Massachusetts General Hospital, Boston, Mass (S.I.L.); Roswell Park Cancer Institute, Buffalo, NY (S.A.); Department of Radiation Oncology, University of Washington Medical Center, Seattle, Wash (W.J.K.); University of Oklahoma Health Sciences Center, Oklahoma City, Okla (R.S.M., K.M.M.); Department of Gynecologic Oncology, Women and Infants Hospital, Providence, RI (P.D.); Seattle Cancer Care Alliance, Seattle, Wash (S.A.K.); School of Medicine, Stony Brook University Health Sciences Center, Stony Brook, NY (M.P.); Department of Gynecologic Oncology, University of Connecticut School of Medicine Hartford HealthCare Cancer Institute at the Hospital of Central Connecticut, New Britain, Conn (X.C.Z.); Department of Obstetrics and Gynecology, Laval University, Quebec City, Quebec, Canada (M.P.); and Department of Gynecologic Oncology, Tulsa Cancer Institute, Tulsa, Okla (M.G.).

View Article

Download full-text PDF

Source
http://pubs.rsna.org/doi/10.1148/radiol.2016160200
Publisher Site
http://dx.doi.org/10.1148/radiol.2016160200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410939PMC
May 2017

FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

Gynecol Oncol 2017 05 15;145(2):366-373. Epub 2017 Mar 15.

Queensland University of Technology (QUT) at the Translational Research Institute, Brisbane, Australia; Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.02.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433848PMC
May 2017

An Isolated Metastasis From Clear Cell Renal Cell Carcinoma to the Uterus: A Case Report and Review of Literature.

Int J Gynecol Pathol 2016 Sep;35(5):419-22

Department of Pathology and Laboratory Medicine (K.S., W.D.L., M.R.Q.) Program in Women's Oncology (P.A.D.), Women & Infants Hospital, Alpert Medical School of Brown University, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000253DOI Listing
September 2016

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.

J Clin Oncol 2016 09 20;34(25):3062-8. Epub 2016 Jun 20.

D. Scott McMeekin and Lisa M. Landrum, University of Oklahoma Health Sciences Center, Oklahoma City, OK; David L. Tritchler, Heather A. Lankes, and Shamshad Ali, NRG Oncology Statistics and Data Management Center; Shashikant B. Lele, Roswell Park Cancer Institute, Buffalo; Michael L. Pearl, Stony Brook University Hospital, Stony Brook, NY; David E. Cohn, Floor J. Backes, and Paul J. Goodfellow, The Ohio State University; Nilsa Ramirez, Research Institute at Nationwide Children's Hospital, Columbus, OH; David G. Mutch, Matthew A. Powell, and Feng Gao, Washington University School of Medicine, St. Louis, MO; Melissa A. Geller, University of Minnesota, Minneapolis, MN; Richard Zaino, Penn State Milton S. Hersey Medical Center, Hershey, PA; Russell D. Broaddus, The University of Texas MD Anderson Cancer Center, Houston, TX; Kathleen M. Darcy, Women's Health Integrated Research Collective, Annandale, VA; and Paul A. DiSilvestro, Women and Infants Hospital of Rhode Island, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.8722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012715PMC
September 2016

Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.

Gynecol Oncol 2016 06 26;141(3):492-496. Epub 2016 Apr 26.

Program in Women's Oncology, Department of Obstetrics and Gynecology, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, RI 02905, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877238PMC
June 2016

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.

N Engl J Med 2016 Feb;374(8):738-48

From the California Pacific-Palo Alto Medical Foundation, Sutter Cancer Research Institute, San Francisco (J.K.C.); NRG Oncology-Gynecologic Oncology Group Statistics and Data Center, Roswell Park Cancer Institute, Buffalo, NY (M.F.B., H.H.); Massachusetts General Hospital, Boston (R.T.P., M.J.B.); University of Oklahoma, Oklahoma City (J.L.W.); Women and Infants Hospital, Providence, RI (P.A.D.S.); University of Pennsylvania (S.C.R.) and Fox Chase Cancer Center (L.P.M.) - both in Philadelphia; University of Colorado Cancer Center, Aurora (S.A.D.); University of Alabama at Birmingham, Birmingham (W.K.H.); James Cancer Center, Ohio State University, Columbus (D.M.O.); Minnesota Oncology/Hematology-Oncology Service, Edina (M.P.B.); Indiana University School of Medicine, Carmel (H.M.); and University of Arizona Cancer Center, Creighton University School of Medicine, and St. Joseph's Hospital and Medical Center (B.J.M.) - all in Phoenix.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081077PMC
http://dx.doi.org/10.1056/NEJMoa1505067DOI Listing
February 2016

Anal Cytology and Human Papillomavirus Genotyping in Women With a History of Lower Genital Tract Neoplasia Compared With Low-Risk Women.

Obstet Gynecol 2015 Dec;126(6):1294-300

Women & Infants Hospital, the Department of Pathology, the Warren Alpert Medical School of Brown University, the Program in Women's Oncology, University Surgical Associates, and the Division of Research and Department of Epidemiology, Brown University, School of Public Health, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000001135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868083PMC
December 2015

Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.

J Clin Oncol 2015 Dec 9;33(36):4301-8. Epub 2015 Nov 9.

Paul J. Goodfellow, Caroline C. Billingsley, David E. Cohn, Heather Hampel, Alexis S. Chassen, Luke V. Simmons, and Floor Backes, Ohio State University; Nilsa Ramirez, Research Institute at Nationwide Children's Hospital, Columbus, OH; Heather A. Lankes and Shamshad Ali, NRG Oncology Statistics and Data Management Center; Shashikant B. Lele, Roswell Park Cancer Institute, Buffalo; Michael L. Pearl, Stony Brook University Hospital, Stony Brook, NY; Russell J. Broaddus, University of Texas MD Anderson Cancer Center, Houston, TX; Colin C. Pritchard, University of Washington, Seattle, WA; Amy P. Schmidt, Feng Gao, Matthew A. Powell, and David Mutch, Washington University School of Medicine, St Louis, MO; Louise A. Brinton, National Cancer Institute, Washington, DC; Lisa M. Landrum, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Melissa A. Geller, University of Minnesota, Minneapolis, MN; Paul A. DiSilvestro, Women and Infants Hospital of Rhode Island, Providence, RI; and Richard J. Zaino, Penn State Milton S. Hershey Medical Center, Hershey, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.9518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678181PMC
December 2015

Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass.

Gynecol Oncol 2015 Nov 11;139(2):248-52. Epub 2015 Sep 11.

Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital, Alpert Medical School at Brown University, Providence, RI 02905, USA; Center for Biomarkers and Emerging Technology, Department of Obstetrics and Gynecology, Women and Infants' Hospital, Alpert Medical School at Brown University, Providence, RI 02905, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258153012
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2015.09.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868067PMC
November 2015

Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.

J Clin Oncol 2015 Jul 2;33(19):2136-42. Epub 2015 Mar 2.

Peter G. Rose, Cleveland Clinic Foundation and Case Western Reserve University, Cleveland, OH; James Java, Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY; Charles W. Whitney, Christiana Gynecologic Oncology, Apex Medical Center, Newark, DE; Frederick B. Stehman, Mel and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN; Rachelle Lanciano, Delaware County Regional Cancer Center, Drexel Hill, PA; Gillian M. Thomas, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; and Paul A. DiSilvestro, Women and Infants Hospital, Brown University, Providence, RI.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.57.7122
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.7122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477785PMC
July 2015

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

Authors:
Sophie Blein Claire Bardel Vincent Danjean Lesley McGuffog Sue Healey Daniel Barrowdale Andrew Lee Joe Dennis Karoline B Kuchenbaecker Penny Soucy Mary Beth Terry Wendy K Chung David E Goldgar Saundra S Buys Ramunas Janavicius Laima Tihomirova Nadine Tung Cecilia M Dorfling Elizabeth J van Rensburg Susan L Neuhausen Yuan Chun Ding Anne-Marie Gerdes Bent Ejlertsen Finn C Nielsen Thomas Vo Hansen Ana Osorio Javier Benitez Raquel Andrés Conejero Ena Segota Jeffrey N Weitzel Margo Thelander Paolo Peterlongo Paolo Radice Valeria Pensotti Riccardo Dolcetti Bernardo Bonanni Bernard Peissel Daniela Zaffaroni Giulietta Scuvera Siranoush Manoukian Liliana Varesco Gabriele L Capone Laura Papi Laura Ottini Drakoulis Yannoukakos Irene Konstantopoulou Judy Garber Ute Hamann Alan Donaldson Angela Brady Carole Brewer Claire Foo D Gareth Evans Debra Frost Diana Eccles Fiona Douglas Jackie Cook Julian Adlard Julian Barwell Lisa Walker Louise Izatt Lucy E Side M John Kennedy Marc Tischkowitz Mark T Rogers Mary E Porteous Patrick J Morrison Radka Platte Ros Eeles Rosemarie Davidson Shirley Hodgson Trevor Cole Andrew K Godwin Claudine Isaacs Kathleen Claes Kim De Leeneer Alfons Meindl Andrea Gehrig Barbara Wappenschmidt Christian Sutter Christoph Engel Dieter Niederacher Doris Steinemann Hansjoerg Plendl Karin Kast Kerstin Rhiem Nina Ditsch Norbert Arnold Raymonda Varon-Mateeva Rita K Schmutzler Sabine Preisler-Adams Nadja Bogdanova Markov Shan Wang-Gohrke Antoine de Pauw Cédrick Lefol Christine Lasset Dominique Leroux Etienne Rouleau Francesca Damiola Hélène Dreyfus Laure Barjhoux Lisa Golmard Nancy Uhrhammer Valérie Bonadona Valérie Sornin Yves-Jean Bignon Jonathan Carter Linda Van Le Marion Piedmonte Paul A DiSilvestro Miguel de la Hoya Trinidad Caldes Heli Nevanlinna Kristiina Aittomäki Agnes Jager Ans Mw van den Ouweland Carolien M Kets Cora M Aalfs Flora E van Leeuwen Frans Bl Hogervorst Hanne Ej Meijers-Heijboer Jan C Oosterwijk Kees Ep van Roozendaal Matti A Rookus Peter Devilee Rob B van der Luijt Edith Olah Orland Diez Alex Teulé Conxi Lazaro Ignacio Blanco Jesús Del Valle Anna Jakubowska Grzegorz Sukiennicki Jacek Gronwald Jan Lubinski Katarzyna Durda Katarzyna Jaworska-Bieniek Bjarni A Agnarsson Christine Maugard Alberto Amadori Marco Montagna Manuel R Teixeira Amanda B Spurdle William Foulkes Curtis Olswold Noralane M Lindor Vernon S Pankratz Csilla I Szabo Anne Lincoln Lauren Jacobs Marina Corines Mark Robson Joseph Vijai Andreas Berger Anneliese Fink-Retter Christian F Singer Christine Rappaport Daphne Geschwantler Kaulich Georg Pfeiler Muy-Kheng Tea Mark H Greene Phuong L Mai Gad Rennert Evgeny N Imyanitov Anna Marie Mulligan Gord Glendon Irene L Andrulis Sandrine Tchatchou Amanda Ewart Toland Inge Sokilde Pedersen Mads Thomassen Torben A Kruse Uffe Birk Jensen Maria A Caligo Eitan Friedman Jamal Zidan Yael Laitman Annika Lindblom Beatrice Melin Brita Arver Niklas Loman Richard Rosenquist Olufunmilayo I Olopade Robert L Nussbaum Susan J Ramus Katherine L Nathanson Susan M Domchek Timothy R Rebbeck Banu K Arun Gillian Mitchell Beth Y Karlan Jenny Lester Sandra Orsulic Dominique Stoppa-Lyonnet Gilles Thomas Jacques Simard Fergus J Couch Kenneth Offit Douglas F Easton Georgia Chenevix-Trench Antonis C Antoniou Sylvie Mazoyer Catherine M Phelan Olga M Sinilnikova David G Cox

Breast Cancer Res 2015 Apr 25;17:61. Epub 2015 Apr 25.

INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-015-0567-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478717PMC
April 2015

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.

J Clin Oncol 2014 Oct 8;32(29):3275-83. Epub 2014 Sep 8.

Mark E. Sherman, Phuong L. Mai, Lori Minasian, and Mark H. Greene, National Cancer Institute, Rockville; Olga B. Ioffe, University of Maryland Medical Center; Brigitte M. Ronnett, Johns Hopkins Medical Institutions, Baltimore; Chad A. Hamilton, Walter Reed National Military Medical Center, Bethesda, MD; Marion Piedmonte, Roswell Park Cancer Institute, Buffalo; Stephanie V. Blank, New York University School of Medicine; Noah D. Kauff, Memorial Sloan Kettering Cancer Center; New York, NY; Linda Van Le, University of North Carolina at Chapel Hill, Chapel Hill, NC; Iouri Ivanov, Columbus Cancer Council, Columbus, OH; Maria C. Bell, Sanford University of South Dakota Medical Center, Sioux Falls, SD; Paul DiSilvestro, Women and Infants Hospital, Providence, RI; Krishnansu S. Tewari, University of California Medical Center Irvine, Orange, CA; Katie Wakeley, Tufts University; Steven J. Skates, Massachusetts General Hospital, Boston, MA; S. Diane Yamada, University of Chicago, Chicago; Gustavo Rodriguez, North Shore University Health System, Evanston, IL; David S. Alberts, University of Arizona Cancer Center, Tucson, AZ; Joan L. Walker, University of Oklahoma, Oklahoma City, OK; and Karen Lu, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.1987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178524PMC
October 2014

Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone.

Gynecol Oncol 2014 Jun 11;133(3):416-20. Epub 2014 Mar 11.

Department of Obstetrics and Gynecology, Program in Women's Oncology, Warren Alpert Medical School of Brown University, Women and Infants Hospital, 101 Dudley Street, Providence, RI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.03.010DOI Listing
June 2014

Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study.

J Clin Oncol 2014 Feb 6;32(5):458-64. Epub 2014 Jan 6.

Paul A. DiSilvestro and Margaret M. Steinhoff, Women and Infants Hospital, Providence, RI; Shamshad Ali, Roswell Park Cancer Institute, Buffalo; Yi-Chun Lee, State University of New York Health Science Center, Brooklyn, NY; Peter S. Craighead, Tom Baker Cancer Center, Calgary, Alberta, Canada; Joseph A. Lucci, University of Miami School of Medicine, Miami, FL; David E. Cohn, Ohio State University, Columbus, OH; Nicola M. Spirtos, Women's Cancer Center of Nevada, Las Vegas, NV; Krishnasu S. Tewari, University of California Medical Center, Irvine, Orange, CA; Carolyn Muller, University of New Mexico Memorial Medical Center, Albuquerque, NM; Walter H. Gajewski, Zimmer Cancer Center, Wilmington, NC; and Bradley J. Monk, Creighton University School of Medicine, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912330PMC
February 2014

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.

Authors:
Yuan C Ding Lesley McGuffog Sue Healey Eitan Friedman Yael Laitman Shani- Paluch-Shimon Bella Kaufman Annelie Liljegren Annika Lindblom Håkan Olsson Ulf Kristoffersson Marie Stenmark-Askmalm Beatrice Melin Susan M Domchek Katherine L Nathanson Timothy R Rebbeck Anna Jakubowska Jan Lubinski Katarzyna Jaworska Katarzyna Durda Jacek Gronwald Tomasz Huzarski Cezary Cybulski Tomasz Byrski Ana Osorio Teresa Ramóny Cajal Alexandra V Stavropoulou Javier Benítez Ute Hamann Matti Rookus Cora M Aalfs Judith L de Lange Hanne E J Meijers-Heijboer Jan C Oosterwijk Christi J van Asperen Encarna B Gómez García Nicoline Hoogerbrugge Agnes Jager Rob B van der Luijt Douglas F Easton Susan Peock Debra Frost Steve D Ellis Radka Platte Elena Fineberg D Gareth Evans Fiona Lalloo Louise Izatt Ros Eeles Julian Adlard Rosemarie Davidson Diana Eccles Trevor Cole Jackie Cook Carole Brewer Marc Tischkowitz Andrew K Godwin Harsh Pathak Dominique Stoppa-Lyonnet Olga M Sinilnikova Sylvie Mazoyer Laure Barjhoux Mélanie Léoné Marion Gauthier-Villars Virginie Caux-Moncoutier Antoine de Pauw Agnès Hardouin Pascaline Berthet Hélène Dreyfus Sandra Fert Ferrer Marie-Agnès Collonge-Rame Johanna Sokolowska Saundra Buys Mary Daly Alex Miron Mary Beth Terry Wendy Chung Esther M John Melissa Southey David Goldgar Christian F Singer Muy-Kheng Maria Tea Daphne Gschwantler-Kaulich Anneliese Fink-Retter Thomas V O Hansen Bent Ejlertsen Oskar T Johannsson Kenneth Offit Kara Sarrel Mia M Gaudet Joseph Vijai Mark Robson Marion R Piedmonte Lesley Andrews David Cohn Leslie R DeMars Paul DiSilvestro Gustavo Rodriguez Amanda Ewart Toland Marco Montagna Simona Agata Evgeny Imyanitov Claudine Isaacs Ramunas Janavicius Conxi Lazaro Ignacio Blanco Susan J Ramus Lara Sucheston Beth Y Karlan Jenny Gross Patricia A Ganz Mary S Beattie Rita K Schmutzler Barbara Wappenschmidt Alfons Meindl Norbert Arnold Dieter Niederacher Sabine Preisler-Adams Dorotehea Gadzicki Raymonda Varon-Mateeva Helmut Deissler Andrea Gehrig Christian Sutter Karin Kast Heli Nevanlinna Kristiina Aittomäki Jacques Simard Amanda B Spurdle Jonathan Beesley Xiaoqing Chen Gail E Tomlinson Jeffrey Weitzel Judy E Garber Olufunmilayo I Olopade Wendy S Rubinstein Nadine Tung Joanne L Blum Steven A Narod Sean Brummel Daniel L Gillen Noralane Lindor Zachary Fredericksen Vernon S Pankratz Fergus J Couch Paolo Radice Paolo Peterlongo Mark H Greene Jennifer T Loud Phuong L Mai Irene L Andrulis Gord Glendon Hilmi Ozcelik Anne-Marie Gerdes Mads Thomassen Uffe Birk Jensen Anne-Bine Skytte Maria A Caligo Andrew Lee Georgia Chenevix-Trench Antonis C Antoniou Susan L Neuhausen

Cancer Epidemiol Biomarkers Prev 2012 Aug 22;21(8):1362-70. Epub 2012 Jun 22.

Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-12-0229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415567PMC
August 2012

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.

Obstet Gynecol 2011 Aug;118(2 Pt 1):280-8

Department of Obstetrics and Gynecology and the Center for Biomarkers and Emerging Technologies, Program in Women's Oncology, Women and Infants' Hospital, Brown University, Providence, Rhode Island 02925, USA.

View Article

Download full-text PDF

Source
http://obgyn.med.umich.edu/sites/obgyn.med.umich.edu/files/E
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/AOG.0b013e318224fce2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594110PMC
August 2011

Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P.

J Clin Oncol 2009 Jul 18;27(19):3104-8. Epub 2009 May 18.

Program in Women's Oncology of Women and Infants, Hospital/Warren Alpert Medical School of Brown University, 101 Dudley St, Providence, RI 92905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.6995DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716935PMC
July 2009

Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial.

Gynecol Oncol 2008 Apr 5;109(1):65-70. Epub 2008 Feb 5.

Program in Women's Oncology, Women and Infants' Hospital, Brown University, Providence, RI 02905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.12.027DOI Listing
April 2008

For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?

Am J Clin Oncol 2008 Feb;31(1):39-42

Program in Women's Oncology, Women & Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island 02905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318134ee6fDOI Listing
February 2008

Oral thalidomide as palliative chemotherapy in women with advanced ovarian cancer.

J Palliat Med 2007 Feb;10(1):61-6

Division of Gynecologic Oncology, University of Louisville/Brown Cancer Center, 529 South Jackson Street, Louisville, KY 40202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2006.0083DOI Listing
February 2007

Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.

Gynecol Oncol 2006 Dec 4;103(3):1038-42. Epub 2006 Aug 4.

Program in Womens Oncology, Women and Infants Hospital, 101 Dudley Street, Providence, RI 02905, and Division of Gynecologic Oncology, University of Oklahoma, Oklahoma City 73190, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082580600503
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2006.06.017DOI Listing
December 2006

Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer.

Gynecol Oncol 2006 Feb 5;100(2):417-21. Epub 2005 Dec 5.

Program in Women's Oncology, Women and Infants' Hospital, 101 Dudley Street, Providence, RI 02905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.10.031DOI Listing
February 2006

Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program.

Gynecol Oncol 2006 Jan 28;100(1):149-51. Epub 2005 Sep 28.

Program in Women's Oncology and the Department of Pharmacy, Women and Infants' Hospital, 101 Dudley Street, Providence, RI 02905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.08.004DOI Listing
January 2006

Outcomes of endometrial cancer patients undergoing surgery with gynecologic oncology involvement.

Obstet Gynecol 2002 Oct;100(4):724-9

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, State University of New York at Stony Brook, Stony Brook, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0029-7844(02)02089-6DOI Listing
October 2002

Comparison of tolerance of combination carboplatin and paclitaxel chemotherapy by age in women with ovarian cancer.

Gynecol Oncol 2002 Sep;86(3):316-22

Department of Gynecologic Oncology, Columbia University College of Physicians and Surgeons, 622 W. 168th Street, PH-1666, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
September 2002

A randomized controlled trial of a regular diet as the first meal in gynecologic oncology patients undergoing intraabdominal surgery.

Obstet Gynecol 2002 Aug;100(2):230-4

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, Stony Brook, New York, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/greenjournal/2002/08000/A_Rando
Web Search
http://dx.doi.org/10.1016/s0029-7844(02)02067-7DOI Listing
August 2002